RIKER LAUREN sold PCRX
June 11, 2026 · Form 4 insider transaction
RIKER LAUREN sold 6,115 shares of Pacira BioSciences, Inc. at $23.50 per share, a transaction worth $143.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6,115
Price
$23.50
Total value
$143.7K
InsiderRIKER LAUREN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 11, 2026
Filing dateJune 12, 2026
Shares owned after62,284
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026.